Ortin Global Limited: Parveen Satija Issues Corrigendum to Open Offer Announcement

2 min read     Updated on 11 Feb 2026, 07:55 AM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Mr. Parveen Satija has issued a corrigendum to his February 10, 2026 public announcement regarding the open offer for Ortin Global Limited. The corrigendum clarifies regulatory compliance aspects under SEBI SAST Regulations while maintaining all original offer terms including the ₹14.65 per share price for acquiring 26% stake. All fundamental parameters of the open offer remain unchanged.

32322342

*this image is generated using AI for illustrative purposes only.

Ortin Global Limited's open offer process sees regulatory clarification as Mr. Parveen Satija issues a corrigendum to his original public announcement dated February 10, 2026. The corrigendum, submitted on February 13, 2026, through Rarever Financial Advisors Private Limited, addresses specific regulatory compliance aspects while maintaining all core terms of the original open offer to acquire 26% stake at ₹14.65 per share.

Corrigendum Details and Regulatory Clarifications

The corrigendum specifically clarifies the regulatory framework governing the open offer. Key modifications include updated references to SEBI SAST Regulations and enhanced compliance language:

Modification Area: Updated Details
Regulatory Framework: Regulation 4 read with Regulations 13, 14 and 15(1)
Offer Classification: Triggered Open Offer under Regulation 4
Compliance Basis: SEBI (SAST) Regulations, 2011
Intent Declaration: Acquisition of control of Target Company
Document Date: February 13, 2026

Original Open Offer Terms Remain Unchanged

Despite the regulatory clarifications, all fundamental terms of the open offer continue as originally announced. The acquisition parameters maintain their original structure:

Parameter: Details
Offer Price: ₹14.65 per share
Total Shares Offered: 21,14,162 shares
Percentage of Capital: 26%
Maximum Consideration: ₹3,09,72,473
Payment Mode: Cash
Face Value: ₹10 per share

Triggering Transaction and Share Purchase Agreement

The corrigendum reaffirms that the open offer stems from the Share Purchase Agreement executed on February 10, 2026, between Satija and four promoter sellers. This underlying transaction involves acquisition of 1,00,300 equity shares representing 1.23% of voting capital, valued at ₹14,69,395.

Transaction Aspect: Specification
Triggering Regulation: Regulation 4 of SEBI (SAST) Regulations, 2011
SPA Execution Date: February 10, 2026
Direct Acquisition: 1,00,300 equity shares (1.23%)
Control Intention: Explicitly stated in corrigendum

Manager to the Offer and Documentation

Rarever Financial Advisors Private Limited continues as Manager to the Offer, facilitating all regulatory compliance requirements. The corrigendum bears digital signatures from both Mr. Prasann Bhatt as Authorized Signatory for the Manager and Mr. Parveen Satija as the Acquirer, ensuring proper authorization and accountability.

The document confirms that except for the specific modifications detailed in the corrigendum, all other terms and contents of the original Public Announcement remain unchanged. The corrigendum will be available on SEBI's website at www.sebi.gov.in , ensuring transparency and public accessibility.

Company Profile and Listing Status

Ortin Global Limited maintains its established market presence with dual listing on BSE (Scrip Code: 539287) and NSE (Symbol: ORTINGLOBE). The company's paid-up capital stands at ₹8,13,13,920 with total equity shares of 81,31,392, providing the foundation for the current open offer calculations and regulatory compliance requirements.

Historical Stock Returns for Ortin Global

1 Day5 Days1 Month6 Months1 Year5 Years
+4.98%+27.50%+43.75%+55.92%+65.88%-41.66%

Ortin Global Limited Schedules Board Meeting for February 14, 2026 to Review Q3FY26 Financial Results

1 min read     Updated on 05 Feb 2026, 09:28 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Ortin Global Limited has scheduled a board meeting for February 14, 2026, to consider unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting will be held at the company's registered office in Hyderabad in compliance with SEBI regulations. The company, formerly known as Ortin Laboratories Limited, has notified both BSE and NSE about this meeting as required under listing obligations.

31852686

*this image is generated using AI for illustrative purposes only.

Ortin Global Limited has announced that its board of directors will convene on February 14, 2026, to review and consider the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting will take place at the company's registered office in Hyderabad, Telangana.

Meeting Details and Regulatory Compliance

The board meeting has been scheduled in accordance with Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally notified both major stock exchanges about this upcoming meeting on February 5, 2026.

Meeting Parameter: Details
Date: February 14, 2026
Venue: Registered Office, Hyderabad
Primary Purpose: Review Q3FY26 Financial Results
Reporting Period: Quarter and nine months ended December 31, 2025

Agenda Items

The board meeting will focus on two main agenda items:

  • Financial Results Review: Consideration of unaudited financial results for the quarter and nine months ended December 31, 2025
  • Additional Business: Any other business matters with the permission of the chairperson

Company Information

Ortin Global Limited, formerly known as Ortin Laboratories Limited, operates from its registered office located at D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad, Hyderabad-500020, Telangana. The company is incorporated under CIN: L68200TG1986PLC006885 and is listed on both BSE (Scrip Code: 539287) and NSE (Symbol: ORTINGLOBE).

Stock Exchange Notification

The announcement was signed by S. Murali Krishna Murthy, Managing Director (DIN: 00540632), and submitted to both the Bombay Stock Exchange and National Stock Exchange of India Limited. This notification ensures compliance with mandatory disclosure requirements for listed companies regarding board meetings that will consider financial results.

The company maintains its corporate communications through email at info@ortinlabsindia.com and operates its official website at www.ortinlabsindia.com . Stakeholders and investors can expect the financial results to be announced following the board meeting on February 14, 2026.

Historical Stock Returns for Ortin Global

1 Day5 Days1 Month6 Months1 Year5 Years
+4.98%+27.50%+43.75%+55.92%+65.88%-41.66%

More News on Ortin Global

1 Year Returns:+65.88%